Ovid Therapeutics Inc. Gains 36.49%
Wed, Mar 03, 2021 at 05:30 PM
Ovid Therapeutics Inc. (OVID:NASDAQ) shot up at $4.04, representing a gain of 36.5%. The stock appeared on our News Catalysts scanner on Wed 03 Mar 21 at 11:20 AM in the 'BIOTECH' category. From Tue 16 Feb 21, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Tue 16 Feb 21 at $3.97 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Ovid Therapeutics Inc. (OVID:NASDAQ)
Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders.
Top 10 Gainers:
- Cohen & Company Inc. (COHN:NYSEMKT), 133.62%
- VectoIQ Acquisition Corp. (VTIQ:NASDAQ), 100%
- Veritiv Corporation (VRTV:NYSE), 40.99%
- 1895 Bancorp of Wisconsin, Inc. (BCOW:NASDAQ), 37.44%
- Ovid Therapeutics Inc. (OVID:NASDAQ), 36.49%
- Super League Gaming, Inc. (SLGG:NASDAQ), 29.93%
- YGMZ (YGMZ:NASDAQ), 25.18%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- The Michaels Companies, Inc. (MIK:NASDAQ), 22.2%
- Nam Tai Property Inc. (NTP:NYSE), 21.44%